Peter Wirth's Insider Trades & SAST Disclosures
Peter Wirth's most recent trade in Zai Lab Limited - ADR was a trade of 21,253 American Depositary Shares done . Disclosure was reported to the exchange on June 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peter Wirth.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Limited - ADR | Peter Wirth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 21,253 | 382,919 (0%) | 0% | 0 | American Depositary Shares | |
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 05 Jun 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | ||
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 05 Jun 2024 | 4,000 | 16,000 (0%) | 0% | 0 | Common Stock | ||
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 01 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | ||
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 01 Jun 2023 | 4,000 | 12,000 (0%) | 0% | 0 | Common Stock | ||
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 16 Sep 2022 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | ||
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 16 Sep 2022 | 8,000 | 8,000 (0%) | 0% | 0 | Common Stock | ||
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 01 Jun 2022 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | ||
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 08 Jun 2021 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | ||
| Syros Pharmaceuticals Inc. | Peter Wirth | Director | 11 Jun 2020 | 17,500 | 17,500 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges